Civic AI
Procurement intelligence
Federal contract award
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC · Department of Health and Human Services
- Value
- $2,475,623
- Start
- May 10, 2024
- End
- Nov 9, 2026
- Action date
- Jan 6, 2026
- PIID
- 75N93024C00008
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- NEW YORK, NY
- Award type
- DEFINITIVE CONTRACT
Description
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
Need modifications, related awards, and vendor peers? Open the full award workspace.